World's largest public-private antibiotic fund unveils first investments
The AMR Action Fund, established in the summer of 2020 by an extensive consortium of some of the world’s leading pharmaceutical companies including Novo Nordisk, is ready to announce its first two investments in the first against antimicrobial resistance (AMR).
by albert rønning-andersson, translated by daniel pedersen
Around two years after the AMR Action Fund came into existence with the goal of aiding the development of new antibiotic drugs, the fund has announced its first two investments, a press release reports.
In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.
The US retail chain has stopped selling its own private label hearing aids – and until the next generation comes along, other hearing companies selling products via Costco are enjoying the empty shelf space.